Target intelligence / Profile preview

NAD-dependent protein lipoamidase sirtuin-4 (SIRT4)

Target
SIRT4
Molecular classification
Enzyme, Sirtuin family, Class III Histone Deacetylase, NAD-dependent protein deacylase, ADP-ribosyltransferase, Lipoamidase
01

Overview

NAD-dependent protein lipoamidase sirtuin-4 (SIRT4) is a mitochondrial enzyme belonging to the sirtuin family of NAD+-dependent deacylases. It plays a critical role in cellular energy sensing and metabolic homeostasis by regulating key enzymes through post-translational modifications, including ADP-ribosylation, deacetylation, and lipoamidation. SIRT4 primarily acts as a negative regulator of insulin secretion by inhibiting glutamate dehydrogenase (GDH) and suppresses glutamine metabolism, which often confers a tumor-suppressive role in various cancers. However, its biological impact is context-dependent, as it also inhibits fatty acid oxidation and can promote cell survival under specific genotoxic stress conditions. While SIRT4 is a promising therapeutic target for metabolic diseases and oncology, the development of selective pharmacological modulators is currently in the preclinical stage, with research focusing on small-molecule inhibitors and activators to fine-tune mitochondrial function.

Other names
Sirtuin 4SIR2L4SIR2-like protein 4NAD-dependent ADP-ribosyltransferase sirtuin-4NAD-dependent protein deacetylase sirtuin-4NAD-dependent protein biotinylase sirtuin-4
02

Mechanism of action

SIRT4 modulates target proteins through ADP-ribosylation, deacetylation, and delipoylation, thereby regulating metabolic flux in the mitochondria.

03

Biological functions

Mitochondrial metabolism regulationInsulin secretion regulationFatty acid oxidation inhibitionGlutamine metabolism regulationATP homeostasisDNA damage responseCell cycle regulationApoptosis regulation
04

Disease associations

CancerType 2 diabetesObesityNonalcoholic fatty liver diseaseCardiovascular diseaseNeurodegenerative diseaseInflammation
05

Safety considerations

Risk of hyperinsulinemia and insulin resistanceContext-dependent oncogenic potentialMetabolic side effects due to broad mitochondrial regulation
06

Interacting drugs

Suramin

6 more in the full profile.

07

Biomarkers

SIRT4 mRNA expressionSIRT4 protein levelsCirculating SIRT4 levels

Beyond the preview

Go deeper on NAD-dependent protein lipoamidase sirtuin-4 (SIRT4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NAD-dependent protein lipoamidase sirtuin-4 (SIRT4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call